logo-loader

Adverum Biotechnlogies Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$751.8 m
Price
11.64 USD
Change
-1.52%
52 weeks high
16.38
52 weeks low
2.90

In brief

Adverum Biotechnologies Inc (ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases.